Highly Sensitive and Robust UPLC-MS/MS Quantification of Nitrosamine Impurities in Sartan and Ranitidine Drug Substances
Applications | 2020 | WatersInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerWaters
Key wordsnitrosamine, ranitidine, ndma, nmba, neipa, ndipa, impurities, ndba, ndea, drug, quantification, blank, six, nitrosamines, uplc, recalls, brief, xevo, sensitive, acquity, substances, careprofessionals, technology, alerting, gti, sartans, plus, daughter, sartan, voluntary, retentivity, irbesartan, medications, losartan, mutagenic, mrm, robust, class, valsartan, initial, waters, hss, curve, arb, weighting, statement, highly, nitroso, patients, carcinogenic
Similar PDF
High Sensitivity Quantitation of Nitrosamine Genotoxic Impurities: LC-MS Analysis of Ranitidine Drug Product using the Waters ACQUITY UPLC I-Class/Xevo TQ-XS Tandem Quadrupole Mass Spectrometer
2020|Waters|Applications
[ APPLICATION NOTE ] High Sensitivity Quantitation of Nitrosamine Genotoxic Impurities: LC-MS Analysis of Ranitidine Drug Product using the Waters ACQUITY UPLC I-Class/Xevo TQ-XS Tandem Quadrupole Mass Spectrometer Mary Trudeau Lame and Lindsay Hatch Waters Corporation, Milford, MA, USA APPLICATION…
Key words
ndma, ndmaranitidine, ranitidinenitrosamine, nitrosaminedrug, drugnmba, nmbablank, blankndba, ndbandea, ndeandipa, ndipaproduct, productarea, areaxevo, xevoneipa, neipauplc, uplcimpurities
Highly Sensitive and Robust UPLC-MS/MS Quantification of Nitrosamine Impurities in Sartan and Ranitidine Drug Substances
2020|Waters|Posters
Highly Sensitive and Robust UPLC-MS/MS Quantification of Nitrosamine Impurities in Sartan and Ranitidine Drug Substances Mary Trudeau Lame , Lindsay Hatch, Dave Higton, Paul Rainville, and Gordon Fujimoto Waters Corporation, Milford, MA, USA 2. UPLC Chromatographic Separation of Nitrosamine Impurities…
Key words
blank, blankranitidine, ranitidinendma, ndmadrug, drugmilford, milfordndea, ndeagti, gtisartan, sartanneipa, neipandipa, ndipandba, ndbanitrosamine, nitrosamineimpurities, impuritieslorsartan, lorsartanformulation
Reliable HPLC/UV Quantification of Nitrosamine Impurities in Valsartan and Ranitidine Drug Substances
2019|Waters|Applications
[ TECHNOLOGY BRIEF ] Reliable HPLC/UV Quantification of Nitrosamine Impurities in Valsartan and Ranitidine Drug Substances Margaret Maziarz and Paul Rainville Waters Corporation, Milford, MA, USA The ACQUITY Arc System with PDA Detector, integrated with an ACQUITY QDa Mass Detector…
Key words
nitrosamine, nitrosaminevalsartan, valsartanqda, qdaranitidine, ranitidinemin, minloq, loqimpurities, impuritiesndma, ndmaacquity, acquitynmba, nmbabrief, briefneipa, neipandipa, ndipadrug, drugreliable
Development of a Sensitive High Resolution Mass Spectrometry Method for Quantitation of N-Nitrosamines using Tof MRM on the Xevo G2-XS QTof
2020|Waters|Applications
Application Note Development of a Sensitive High Resolution Mass Spectrometry Method for Quantitation of N-Nitrosamines using Tof MRM on the Xevo G2-XS QTof Lauren Mullin, Margaret Maziarz, Mary E. Lame, Nathan Anderson Waters Corporation This is an Application Brief and…
Key words
nitrosamines, nitrosaminessartan, sartannitrosamine, nitrosaminetof, tofunifi, unifiinformatics, informaticsmrm, mrmclass, classhrms, hrmsgastroesophageal, gastroesophagealgxp, gxppusher, pusherplatform, platformstomach, stomachuplc